Sabiston Ch52 — Infectious & Ischemic Colitis

Citation: Galandiuk S, Netz U, Morpurgo E, Tosato SM, Abu-Freha N, Ellis CT. Chapter 52: Colon and Rectum. In: Sabiston Textbook of Surgery, 21st ed. Elsevier; pp. 1355–1362 (this chunk).

Source type: Textbook chapter — reference source, not a primary study. See Sabiston Ch52 - Diverticular Disease, Obstruction & Pseudo-Obstruction for the general note on how this chapter is used in the wiki.

This is chunk 3 of the chapter (chunk 1: diverticular disease/obstruction/Ogilvie syndrome; chunk 2: IBD). Still to come: neoplasia/staging, rectal cancer surgery, pelvic floor disorders — chunk 4 begins right where this one ends (Colorectal Cancer Genetics).

Scope of this chunk

Pages 1355–1362: Infectious Colitis (C. difficile infection in detail, then a table of other enteric pathogens) and Ischemic Colitis (epidemiology, watershed anatomy, diagnosis, treatment, surgical technique).

Filing

Note on a source error

The chapter’s Table 52.5 lists Campylobacter jejuni as a “gram-positive rod.” This is incorrect — Campylobacter is a well-established gram-negative organism (spiral/curved gram-negative rod). Corrected in Infectious Colitis rather than propagated; flagging here per the wiki’s convention of noting when a source’s claims conflict with established fact.

Relevance

Like the prior two chunks, this is background/orientation rather than primary evidence — no specific trial or cohort study is cited for any individual claim. The C. difficile treatment table (vancomycin/fidaxomicin over metronidazole as first-line) reflects a real and relatively recent practice shift worth cross-checking against current IDSA/SHEA guidelines directly if a specific antibiotic decision is being made. The ischemic colitis surgical-technique content (ICG angiography, no-revascularization point) is genuinely useful practical detail not likely to change quickly.